Good News: ScienTech Medical obtained identifications for two high-tech transformation projects

        Recently, Shanghai Shape Memory Alloy Co., Ltd., a wholly owned subsidiary of Lepu ScienTech Medical Technology (Shanghai) Co., Ltd. (known as 'ScienTech Medical'), obtained identification for two high-tech achievement transformation projects—the "Fully Biodegradable Occluder System"( project no.: 202301063) and the "Interventional Occluder Delivery System" (project no.: 202301064). These innovative projects were identified by the Science and Technology Commission of Shanghai Municipality for the year 2023.

Certificate of the Science and Technology Commission of Shanghai Municipality

           The high-tech achievement transformation projects refer to projects that conform to the "High-tech Fields Supported by the Government Official." These projects also include subsequent experiments, development, application, promotion, and the development of new processes, materials, products, and industries, which leverage technology achievements with practical value, ultimately enhancing productivity and innovation.
         

          Securing recognition for two high-tech achievement transformation projects stands as a testament to our innovation and substantial investments in R&D in the fields of interventional medical device used for structural heart disease. It also validates our ability to effectively translate research outcomes into tangible results. It is also the recognition of the innovative medical equipment business capability with forward-looking, progressiveness and excellent and specialized enterprise development strategy.

Research Achievements and Innovative Contributions

Fully Biodegradable Occluder System–Project Advantages and Contributions

                           Fully Biodegradable Occluder System–Project Advantages and Contributions

          The innovative MemoSorb® Fully Biodegradable Occluder System represents a groundbreaking advancement, transitioning occluders from traditional metal materials to fully biodegradable materials. When implanted in the human body, the occluder serves as a temporary bridge and gradually degrades after successfully promoting the regeneration of autologous tissues. After approximately one year, it will completely dissolve and leave no residue. This innovative approach mitigates the safety risks associated with the permanent retention of traditional metal occluders. The system features a patented locking design and a symmetrical wide-edge design, which ensures stable formation and preventing detachment. These features significantly enhance the safety of congenital heart disease heart surgery. Additionally, a range of sizes and models tailored to diverse anatomical structures are available, which can minimize compression wear, and effectively lower long-term risks. The introduction and clinical application of this medical device in various regions across the country have brought numerous benefits to many patients with congenital heart disease by significant and enduring advantages, especially for children.

Interventional Occluder Delivery System—Advantages and Contributions of these 2 projects

        The Gruiser™ Interventional Occluder Delivery System is a novel product designed to assist in delivering biodegradable occluders into the heart chambers. It also establishes a percutaneous access route for intravascular devices, and streamlines intricate interventional procedures. It features an innovative design and an extensive array of models. Different from conventional occluder delivery systems, this product incorporates a patented head-end encircling design with "alligator clamp teeth" and encircled clamping. This design securely fastens the occluder, simplifying both delivery and withdrawal processes. Additionally, the system integrates a locking control handle design, which ensures the secure connection of clamp teeth and the safety of the delivery operation throughout the procedure.

Endless Development and Continuous Innovation

         Science and technology are a primary productive force, so the transformation of technological achievements is a critical link in the integration of technology and the economy. It serves as a direct and effective means to promote economic development. It is very important to improve the efficiency and quality of technology transfer within a company for its healthy development. In the future, ScienTech Medical will persist in enhancing its technological strengths, expending research and development investments, and strengthening its independent innovation capabilities. Collaborative efforts with academic and research institutions will be intensified to foster additional technology innovation projects, facilitating the seamless transition of research outcomes into tangible benefits. This steadfast commitment aims to fortify the industry's value chain, augment the company's reputation, and bolster its long-term development.